Active Ingredient History
There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate. NCATS
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Colitis, Ulcerative (approved 1955)
Dermatitis (approved 2006)
Gastrointestinal Diseases (approved 1987)
Renal Insufficiency (approved 2012)
Acne Vulgaris (Phase 3)
Alopecia (Phase 1/Phase 2)
Amyotrophic Lateral Sclerosis (Phase 1/Phase 2)
Anemia (Phase 4)
Anemia, Sickle Cell (Phase 3)
Antioxidants (Phase 4)
Attention Deficit Disorder with Hyperactivity (Phase 2/Phase 3)
Autistic Disorder (Phase 1)
beta-Thalassemia (Phase 3)
Cataract (Phase 3)
Central Serous Chorioretinopathy (Phase 2)
Cerebral Ventriculitis (Phase 4)
Child (Phase 3)
Child Development (Phase 3)
Child Nutrition Disorders (Phase 4)
Cholera (Phase 3)
Condylomata Acuminata (Phase 4)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 4)
Critical Illness (Phase 3)
Deficiency Diseases (Phase 3)
Dermatology (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 2)
Diaper Rash (Phase 4)
Diarrhea (Phase 4)
Dysgeusia (Phase 3)
Endometriosis (Phase 2)
Enterocolitis, Necrotizing (Phase 4)
Fatigue Syndrome, Chronic (Phase 4)
Fertility (Early Phase 1)
Fever (Phase 3)
Gingival Diseases (Phase 3)
Gingivitis (Phase 3)
Graves Ophthalmopathy (Phase 2/Phase 3)
Growth (Phase 3)
Growth and Development (Phase 3)
Hepatitis, Alcoholic (Phase 2)
Hepatolenticular Degeneration (Phase 3)
Herpes Labialis (Phase 3)
HIV Infections (Phase 3)
Hospitalization (Phase 3)
Human papillomavirus 16 (Phase 4)
Hyaline Membrane Disease (Phase 4)
Hyperglycemia (Phase 4)
Hypogonadism (Phase 4)
Immune System Diseases (Phase 1)
Infections (Phase 3)
Infertility, Male (Phase 4)
Iron (Phase 4)
Iron Deficiencies (Phase 3)
Kallmann Syndrome (Phase 4)
Kidney Failure, Chronic (Phase 3)
Lichen Planus, Oral (Phase 4)
Lung Diseases (Phase 3)
Macular Degeneration (Phase 3)
Malaria (Phase 4)
Malnutrition (Phase 4)
Menopause (Phase 1)
Mucositis (Phase 3)
Pediatrics (Phase 1/Phase 2)
Pneumonia (Phase 4)
Poliovirus Vaccine, Oral (Phase 4)
Prediabetic State (Phase 4)
Pregnancy (Phase 3)
Premature Birth (Phase 4)
Renal Insufficiency, Chronic (Phase 3)
Respiratory Tract Infections (Phase 4)
Rotavirus Infections (Phase 4)
Semen Analysis (Phase 4)
Sepsis (Phase 3)
Serum (Phase 2/Phase 3)
Severe Acute Respiratory Syndrome (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Subarachnoid Hemorrhage (Phase 3)
Thalassemia (Phase 2)
Thoracic Surgery (Phase 3)
Trace Elements (Phase 3)
Triple Negative Breast Neoplasms (Early Phase 1)
Tuberculosis (Phase 3)
Vitamin A Deficiency (Early Phase 1)
Wounds and Injuries (Phase 3)
Zinc (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue